25 related articles for article (PubMed ID: 6113999)
21. [Inhibition of menstrual uterine motility with four beta-adrenergic drugs (author's transl)].
Cifuentes R; Cobo E
Reproduccion; 1981; 5(1):31-41. PubMed ID: 6113999
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.
Hochhaus G; Möllmann H
Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):342-62. PubMed ID: 1358833
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy of preterm labor.
Souney PF; Kaul AF; Osathanondh R
Clin Pharm; 1983; 2(1):29-44. PubMed ID: 6136361
[TBL] [Abstract][Full Text] [Related]
24. [Antispasmodic agents (author's transl)].
Colasson F; Kamina P; Courtois P; de Tourris H
J Gynecol Obstet Biol Reprod (Paris); 1980; 9(3):377-88. PubMed ID: 6109743
[TBL] [Abstract][Full Text] [Related]
25. Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
Bardou M; Rouget C; Breuiller-Fouché M; Loustalot C; Naline E; Sagot P; Frydman R; Morcillo EJ; Advenier C; Leroy MJ; Morrison JJ
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S14. PubMed ID: 17570158
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
